Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
+0.030 (0.67%)
Apr 17, 2026, 4:08 PM HKT
Market Cap1.09B +51.0%
Revenue (ttm)50.00M
Net Income-77.96M
EPS-0.32
Shares Out243.42M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume255,400
Average Volume322,650
Open4.640
Previous Close4.470
Day's Range4.450 - 4.640
52-Week Range2.050 - 10.770
Beta0.11
RSI52.69
Earnings DateMar 26, 2026

About HKG:2185

Shanghai Bio-heart Biological Technology Co., Ltd. an interventional cardiovascular device company, engages in the research and development of therapies for unmet medical needs of patients in the People’s Republic of China. The company develops Bioheart, a bioresorbable scaffolds (BRS) system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a renal denervation (RDN) product candidate for the treatment of uncontrolled hypertension and resistant hypertension; and drug coated balloon (... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 70
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2185
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements